Various USP6 inhibitors such as Momelotinib (CYT387), FT385, USP30 Inh-1, -2 and -3, 2,6-Diaminopyridine-3,5-bis(thiocyanate) (PR-619), and miR-130a were identified against tumor cancers, uveal melanoma, and osteosarcoma[21]. The gene discussed is USP6; the disease is uveal melanoma.